Product Details | USP PANCRELIPASE DELEAYED-RELEASE CAPSULES

6505-01-289-2005 00001016505000000

Part Alternates: NDC00045034360, NDC00045-0343-60, PANCREASE MT 16, PANCREASEMT16, 6505-01-289-2005, 01-289-2005, 6505012892005, 012892005

Medical, Dental, and Veterinary Equipment and Supplies | Drugs and Biologicals

Supply Group (FSG) NSN Assign. NIIN
65 01-289-2005

Request a Quote

What Our Customers Say

Compare

NSNs for Compare ( up to 4 ): Add 6505-01-289-2005

Technical Data | NSN 6505-01-289-2005

Characteristic Specifications
CAPSULE TYPE ANY ACCEPTABLE
CAPSULE CONTENT FORM ANY ACCEPTABLE
PRIMARY CONTAINER TYPE BOTTLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY 100.000
EXTERIOR CONTAINER QUANTITY 144
UNIT OF ISSUE WEIGHT 0.19 POUNDS
EXTERIOR CONTAINER WEIGHT 26.70 POUNDS
UNIT OF ISSUE CUBE 0.01 CUBIC FEET
EXTERIOR CONTAINER CUBIC MEASURE 1.61 CUBIC FEET
SPECIAL FEATURES 16,000 USP UNITS LIPASE,8,000 USP UNITS AMYLASE,AND 8,000 USP UNITS PROTEASE
III PART NAME ASSIGNED BY CONTROLLING AGENCY PANCRELIPASE DELAYED-RELEASE CAPSULES 100S BT

Restrictions/Controls & Freight Information | NSN 6505-01-289-2005

Category Code Description
Hazardous Material Indicator CodePThere is no information in the HMIS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product
Category Code Description
No Freight Information